nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—SLCO1A2—Chlorambucil—testicular cancer	0.0561	0.0666	CbGbCtD
Verapamil—CYP2C18—Ifosfamide—testicular cancer	0.053	0.063	CbGbCtD
Verapamil—ABCC10—Etoposide—testicular cancer	0.0441	0.0524	CbGbCtD
Verapamil—ABCC1—Dactinomycin—testicular cancer	0.0302	0.0358	CbGbCtD
Verapamil—ABCC10—Doxorubicin—testicular cancer	0.0301	0.0357	CbGbCtD
Verapamil—ABCC10—Methotrexate—testicular cancer	0.0291	0.0346	CbGbCtD
Verapamil—SLC22A5—Dactinomycin—testicular cancer	0.0287	0.0341	CbGbCtD
Verapamil—ABCC3—Cisplatin—testicular cancer	0.0282	0.0335	CbGbCtD
Verapamil—ABCC3—Etoposide—testicular cancer	0.0277	0.0329	CbGbCtD
Verapamil—ABCB11—Vinblastine—testicular cancer	0.0266	0.0316	CbGbCtD
Verapamil—ABCC1—Epirubicin—testicular cancer	0.0219	0.026	CbGbCtD
Verapamil—ABCG2—Dactinomycin—testicular cancer	0.0202	0.024	CbGbCtD
Verapamil—ABCC3—Doxorubicin—testicular cancer	0.0189	0.0225	CbGbCtD
Verapamil—ABCC1—Vinblastine—testicular cancer	0.0189	0.0224	CbGbCtD
Verapamil—ABCC3—Methotrexate—testicular cancer	0.0183	0.0218	CbGbCtD
Verapamil—CYP3A7—Ifosfamide—testicular cancer	0.0176	0.0209	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0176	0.0209	CbGbCtD
Verapamil—ABCC1—Etoposide—testicular cancer	0.017	0.0202	CbGbCtD
Verapamil—CYP2B6—Ifosfamide—testicular cancer	0.0168	0.0199	CbGbCtD
Verapamil—ABCB11—Doxorubicin—testicular cancer	0.0164	0.0194	CbGbCtD
Verapamil—ABCC2—Carboplatin—testicular cancer	0.015	0.0178	CbGbCtD
Verapamil—ABCC4—Methotrexate—testicular cancer	0.014	0.0166	CbGbCtD
Verapamil—ABCC2—Vinblastine—testicular cancer	0.014	0.0166	CbGbCtD
Verapamil—ABCG2—Carboplatin—testicular cancer	0.0136	0.0161	CbGbCtD
Verapamil—CYP3A5—Ifosfamide—testicular cancer	0.0132	0.0157	CbGbCtD
Verapamil—ABCC2—Cisplatin—testicular cancer	0.0128	0.0152	CbGbCtD
Verapamil—CYP2C8—Ifosfamide—testicular cancer	0.0127	0.0151	CbGbCtD
Verapamil—ABCC2—Etoposide—testicular cancer	0.0126	0.015	CbGbCtD
Verapamil—ABCC1—Doxorubicin—testicular cancer	0.0116	0.0138	CbGbCtD
Verapamil—ABCG2—Cisplatin—testicular cancer	0.0116	0.0138	CbGbCtD
Verapamil—ABCG2—Etoposide—testicular cancer	0.0114	0.0135	CbGbCtD
Verapamil—ABCC1—Methotrexate—testicular cancer	0.0113	0.0134	CbGbCtD
Verapamil—CYP2C19—Ifosfamide—testicular cancer	0.0107	0.0127	CbGbCtD
Verapamil—SLCO1A2—Methotrexate—testicular cancer	0.01	0.0119	CbGbCtD
Verapamil—SLCO1B1—Methotrexate—testicular cancer	0.00948	0.0113	CbGbCtD
Verapamil—CYP2C9—Ifosfamide—testicular cancer	0.00886	0.0105	CbGbCtD
Verapamil—ABCC2—Doxorubicin—testicular cancer	0.0086	0.0102	CbGbCtD
Verapamil—ABCC2—Methotrexate—testicular cancer	0.00833	0.00989	CbGbCtD
Verapamil—CYP2B6—Cisplatin—testicular cancer	0.00816	0.00969	CbGbCtD
Verapamil—ABCG2—Doxorubicin—testicular cancer	0.00777	0.00923	CbGbCtD
Verapamil—ABCG2—Methotrexate—testicular cancer	0.00753	0.00894	CbGbCtD
Verapamil—ABCB1—Dactinomycin—testicular cancer	0.00728	0.00865	CbGbCtD
Verapamil—CYP3A5—Etoposide—testicular cancer	0.00631	0.0075	CbGbCtD
Verapamil—CYP2C8—Etoposide—testicular cancer	0.00607	0.00721	CbGbCtD
Verapamil—CYP2B6—Doxorubicin—testicular cancer	0.00547	0.00649	CbGbCtD
Verapamil—CYP3A4—Ifosfamide—testicular cancer	0.00515	0.00612	CbGbCtD
Verapamil—CYP1A2—Etoposide—testicular cancer	0.0047	0.00558	CbGbCtD
Verapamil—ABCB1—Vinblastine—testicular cancer	0.00456	0.00542	CbGbCtD
Verapamil—CYP2C9—Cisplatin—testicular cancer	0.00431	0.00512	CbGbCtD
Verapamil—CYP2D6—Vinblastine—testicular cancer	0.0043	0.0051	CbGbCtD
Verapamil—ABCB1—Cisplatin—testicular cancer	0.00418	0.00497	CbGbCtD
Verapamil—ABCB1—Etoposide—testicular cancer	0.00411	0.00488	CbGbCtD
Verapamil—ABCB1—Doxorubicin—testicular cancer	0.0028	0.00333	CbGbCtD
Verapamil—CYP3A4—Vinblastine—testicular cancer	0.00273	0.00325	CbGbCtD
Verapamil—ABCB1—Methotrexate—testicular cancer	0.00271	0.00322	CbGbCtD
Verapamil—CYP2D6—Doxorubicin—testicular cancer	0.00264	0.00314	CbGbCtD
Verapamil—CYP3A4—Etoposide—testicular cancer	0.00246	0.00292	CbGbCtD
Verapamil—CACNA1S—seminal vesicle—testicular cancer	0.00234	0.0494	CbGeAlD
Verapamil—CACNB3—seminal vesicle—testicular cancer	0.00209	0.0442	CbGeAlD
Verapamil—CACNA1I—testis—testicular cancer	0.00173	0.0365	CbGeAlD
Verapamil—CYP3A4—Doxorubicin—testicular cancer	0.00168	0.00199	CbGbCtD
Verapamil—CACNA1H—seminal vesicle—testicular cancer	0.00149	0.0314	CbGeAlD
Verapamil—CACNB4—testis—testicular cancer	0.00142	0.03	CbGeAlD
Verapamil—CACNA1A—testis—testicular cancer	0.00136	0.0287	CbGeAlD
Verapamil—CACNA1B—testis—testicular cancer	0.00133	0.028	CbGeAlD
Verapamil—CACNB1—female gonad—testicular cancer	0.00128	0.027	CbGeAlD
Verapamil—CACNA1I—lymph node—testicular cancer	0.00125	0.0265	CbGeAlD
Verapamil—CACNB3—female gonad—testicular cancer	0.00123	0.0259	CbGeAlD
Verapamil—CACNB1—testis—testicular cancer	0.00114	0.024	CbGeAlD
Verapamil—CACNB3—testis—testicular cancer	0.00109	0.023	CbGeAlD
Verapamil—CACNA1H—gonad—testicular cancer	0.00108	0.0227	CbGeAlD
Verapamil—ABCC10—seminal vesicle—testicular cancer	0.00103	0.0217	CbGeAlD
Verapamil—SLC22A4—seminal vesicle—testicular cancer	0.000965	0.0204	CbGeAlD
Verapamil—CACNA1B—lymph node—testicular cancer	0.000961	0.0203	CbGeAlD
Verapamil—CACNA1H—female gonad—testicular cancer	0.000874	0.0185	CbGeAlD
Verapamil—ABCB11—testis—testicular cancer	0.000845	0.0178	CbGeAlD
Verapamil—CACNB1—lymph node—testicular cancer	0.000824	0.0174	CbGeAlD
Verapamil—CACNB3—lymph node—testicular cancer	0.00079	0.0167	CbGeAlD
Verapamil—KCNJ11—female gonad—testicular cancer	0.000783	0.0165	CbGeAlD
Verapamil—CACNA1H—testis—testicular cancer	0.000775	0.0164	CbGeAlD
Verapamil—ABCC10—gonad—testicular cancer	0.000742	0.0157	CbGeAlD
Verapamil—CACNB2—testis—testicular cancer	0.000732	0.0155	CbGeAlD
Verapamil—ABCC1—seminal vesicle—testicular cancer	0.000726	0.0153	CbGeAlD
Verapamil—KCNH2—seminal vesicle—testicular cancer	0.000676	0.0143	CbGeAlD
Verapamil—CACNA1D—testis—testicular cancer	0.00064	0.0135	CbGeAlD
Verapamil—SLC22A5—seminal vesicle—testicular cancer	0.000639	0.0135	CbGeAlD
Verapamil—ABCC3—female gonad—testicular cancer	0.000606	0.0128	CbGeAlD
Verapamil—ABCC10—female gonad—testicular cancer	0.000603	0.0127	CbGeAlD
Verapamil—ABCG2—seminal vesicle—testicular cancer	0.000601	0.0127	CbGeAlD
Verapamil—CACNA1C—testis—testicular cancer	0.000591	0.0125	CbGeAlD
Verapamil—CACNA1H—lymph node—testicular cancer	0.000562	0.0119	CbGeAlD
Verapamil—ABCC3—testis—testicular cancer	0.000537	0.0113	CbGeAlD
Verapamil—ABCC10—testis—testicular cancer	0.000535	0.0113	CbGeAlD
Verapamil—CACNB2—lymph node—testicular cancer	0.000531	0.0112	CbGeAlD
Verapamil—KCNJ11—lymph node—testicular cancer	0.000504	0.0106	CbGeAlD
Verapamil—ABCC4—female gonad—testicular cancer	0.0005	0.0106	CbGeAlD
Verapamil—CACNA1D—lymph node—testicular cancer	0.000464	0.00979	CbGeAlD
Verapamil—SLCO1A2—testis—testicular cancer	0.000461	0.00973	CbGeAlD
Verapamil—ABCC4—testis—testicular cancer	0.000444	0.00936	CbGeAlD
Verapamil—ABCC2—testis—testicular cancer	0.000429	0.00906	CbGeAlD
Verapamil—CACNA1C—lymph node—testicular cancer	0.000428	0.00904	CbGeAlD
Verapamil—ABCC1—female gonad—testicular cancer	0.000427	0.009	CbGeAlD
Verapamil—CYP2B6—gonad—testicular cancer	0.000401	0.00846	CbGeAlD
Verapamil—KCNH2—female gonad—testicular cancer	0.000397	0.00838	CbGeAlD
Verapamil—ABCC3—lymph node—testicular cancer	0.00039	0.00822	CbGeAlD
Verapamil—ABCC10—lymph node—testicular cancer	0.000388	0.00818	CbGeAlD
Verapamil—ABCC1—testis—testicular cancer	0.000378	0.00798	CbGeAlD
Verapamil—SLC22A5—female gonad—testicular cancer	0.000375	0.00792	CbGeAlD
Verapamil—SLC22A4—lymph node—testicular cancer	0.000364	0.00769	CbGeAlD
Verapamil—ABCG2—female gonad—testicular cancer	0.000353	0.00745	CbGeAlD
Verapamil—KCNH2—testis—testicular cancer	0.000352	0.00743	CbGeAlD
Verapamil—SLC22A5—testis—testicular cancer	0.000333	0.00702	CbGeAlD
Verapamil—CYP3A5—female gonad—testicular cancer	0.000328	0.00692	CbGeAlD
Verapamil—CYP2C8—testis—testicular cancer	0.000322	0.0068	CbGeAlD
Verapamil—ABCC4—lymph node—testicular cancer	0.000322	0.00679	CbGeAlD
Verapamil—ABCB1—embryo—testicular cancer	0.000316	0.00666	CbGeAlD
Verapamil—ABCG2—testis—testicular cancer	0.000313	0.00661	CbGeAlD
Verapamil—ABCC2—lymph node—testicular cancer	0.000311	0.00657	CbGeAlD
Verapamil—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00031	0.05	CbGpPWpGaD
Verapamil—ABCB1—seminal vesicle—testicular cancer	0.000297	0.00626	CbGeAlD
Verapamil—CYP2B6—testis—testicular cancer	0.000289	0.0061	CbGeAlD
Verapamil—ABCC1—lymph node—testicular cancer	0.000274	0.00579	CbGeAlD
Verapamil—KCNH2—lymph node—testicular cancer	0.000255	0.00539	CbGeAlD
Verapamil—CYP2D6—female gonad—testicular cancer	0.000242	0.00511	CbGeAlD
Verapamil—SLC22A5—lymph node—testicular cancer	0.000241	0.00509	CbGeAlD
Verapamil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000233	0.0376	CbGpPWpGaD
Verapamil—ABCG2—lymph node—testicular cancer	0.000227	0.00479	CbGeAlD
Verapamil—CYP2D6—testis—testicular cancer	0.000215	0.00453	CbGeAlD
Verapamil—ABCB1—gonad—testicular cancer	0.000214	0.00452	CbGeAlD
Verapamil—CACNB4—Developmental Biology—PRDM14—testicular cancer	0.000197	0.0318	CbGpPWpGaD
Verapamil—Infection—Cisplatin—testicular cancer	0.000191	0.00183	CcSEcCtD
Verapamil—Pain—Ifosfamide—testicular cancer	0.000191	0.00183	CcSEcCtD
Verapamil—Constipation—Ifosfamide—testicular cancer	0.000191	0.00183	CcSEcCtD
Verapamil—Cardiac failure—Doxorubicin—testicular cancer	0.00019	0.00182	CcSEcCtD
Verapamil—Loss of consciousness—Etoposide—testicular cancer	0.00019	0.00182	CcSEcCtD
Verapamil—Cerebrovascular accident—Doxorubicin—testicular cancer	0.00019	0.00182	CcSEcCtD
Verapamil—Lethargy—Doxorubicin—testicular cancer	0.00019	0.00182	CcSEcCtD
Verapamil—Tachycardia—Cisplatin—testicular cancer	0.000188	0.0018	CcSEcCtD
Verapamil—Asthenia—Bleomycin—testicular cancer	0.000187	0.00179	CcSEcCtD
Verapamil—Convulsion—Etoposide—testicular cancer	0.000187	0.00179	CcSEcCtD
Verapamil—Hypertension—Etoposide—testicular cancer	0.000186	0.00178	CcSEcCtD
Verapamil—Diplopia—Doxorubicin—testicular cancer	0.000186	0.00178	CcSEcCtD
Verapamil—Hyperhidrosis—Cisplatin—testicular cancer	0.000186	0.00178	CcSEcCtD
Verapamil—CACNA1I—Developmental Biology—PRDM14—testicular cancer	0.000185	0.0299	CbGpPWpGaD
Verapamil—Pruritus—Bleomycin—testicular cancer	0.000185	0.00177	CcSEcCtD
Verapamil—Feeling abnormal—Ifosfamide—testicular cancer	0.000184	0.00176	CcSEcCtD
Verapamil—Chest pain—Etoposide—testicular cancer	0.000184	0.00176	CcSEcCtD
Verapamil—Nausea—Vinblastine—testicular cancer	0.000183	0.00176	CcSEcCtD
Verapamil—Orthostatic hypotension—Epirubicin—testicular cancer	0.000183	0.00176	CcSEcCtD
Verapamil—Discomfort—Etoposide—testicular cancer	0.000181	0.00174	CcSEcCtD
Verapamil—Hypotension—Cisplatin—testicular cancer	0.00018	0.00172	CcSEcCtD
Verapamil—Hypersensitivity—Dactinomycin—testicular cancer	0.000179	0.00172	CcSEcCtD
Verapamil—Abdominal discomfort—Methotrexate—testicular cancer	0.000178	0.0017	CcSEcCtD
Verapamil—Confusional state—Etoposide—testicular cancer	0.000178	0.0017	CcSEcCtD
Verapamil—Muscular weakness—Epirubicin—testicular cancer	0.000177	0.0017	CcSEcCtD
Verapamil—Urticaria—Ifosfamide—testicular cancer	0.000177	0.0017	CcSEcCtD
Verapamil—Cardiac arrest—Doxorubicin—testicular cancer	0.000177	0.00169	CcSEcCtD
Verapamil—Anaphylactic shock—Etoposide—testicular cancer	0.000176	0.00169	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000175	0.00168	CcSEcCtD
Verapamil—Infection—Etoposide—testicular cancer	0.000175	0.00168	CcSEcCtD
Verapamil—Asthenia—Dactinomycin—testicular cancer	0.000175	0.00167	CcSEcCtD
Verapamil—ABCB1—female gonad—testicular cancer	0.000174	0.00367	CbGeAlD
Verapamil—Influenza—Epirubicin—testicular cancer	0.000174	0.00166	CcSEcCtD
Verapamil—Paraesthesia—Cisplatin—testicular cancer	0.000173	0.00165	CcSEcCtD
Verapamil—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000172	0.00165	CcSEcCtD
Verapamil—Tachycardia—Etoposide—testicular cancer	0.000172	0.00165	CcSEcCtD
Verapamil—Dyspnoea—Cisplatin—testicular cancer	0.000171	0.00164	CcSEcCtD
Verapamil—Erectile dysfunction—Methotrexate—testicular cancer	0.000171	0.00164	CcSEcCtD
Verapamil—Hyperhidrosis—Etoposide—testicular cancer	0.00017	0.00163	CcSEcCtD
Verapamil—Orthostatic hypotension—Doxorubicin—testicular cancer	0.00017	0.00163	CcSEcCtD
Verapamil—Angina pectoris—Epirubicin—testicular cancer	0.000169	0.00162	CcSEcCtD
Verapamil—ABCC4—Ectoderm Differentiation—TFAP2C—testicular cancer	0.000167	0.0269	CbGpPWpGaD
Verapamil—Diarrhoea—Dactinomycin—testicular cancer	0.000166	0.00159	CcSEcCtD
Verapamil—Vomiting—Bleomycin—testicular cancer	0.000166	0.00159	CcSEcCtD
Verapamil—Drowsiness—Methotrexate—testicular cancer	0.000165	0.00158	CcSEcCtD
Verapamil—Hypotension—Etoposide—testicular cancer	0.000165	0.00158	CcSEcCtD
Verapamil—Rash—Bleomycin—testicular cancer	0.000164	0.00158	CcSEcCtD
Verapamil—Pain—Cisplatin—testicular cancer	0.000164	0.00157	CcSEcCtD
Verapamil—Dermatitis—Bleomycin—testicular cancer	0.000164	0.00157	CcSEcCtD
Verapamil—Hypersensitivity—Ifosfamide—testicular cancer	0.000164	0.00157	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000164	0.00157	CcSEcCtD
Verapamil—Muscular weakness—Doxorubicin—testicular cancer	0.000164	0.00157	CcSEcCtD
Verapamil—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000161	0.00155	CcSEcCtD
Verapamil—Influenza—Doxorubicin—testicular cancer	0.000161	0.00154	CcSEcCtD
Verapamil—Pollakiuria—Epirubicin—testicular cancer	0.00016	0.00154	CcSEcCtD
Verapamil—Asthenia—Ifosfamide—testicular cancer	0.00016	0.00153	CcSEcCtD
Verapamil—Sweating—Methotrexate—testicular cancer	0.000159	0.00152	CcSEcCtD
Verapamil—Feeling abnormal—Cisplatin—testicular cancer	0.000158	0.00152	CcSEcCtD
Verapamil—Paraesthesia—Etoposide—testicular cancer	0.000158	0.00151	CcSEcCtD
Verapamil—Pruritus—Ifosfamide—testicular cancer	0.000158	0.00151	CcSEcCtD
Verapamil—CACNB3—Developmental Biology—PRDM14—testicular cancer	0.000158	0.0254	CbGpPWpGaD
Verapamil—Dyspnoea—Etoposide—testicular cancer	0.000157	0.0015	CcSEcCtD
Verapamil—Somnolence—Etoposide—testicular cancer	0.000157	0.0015	CcSEcCtD
Verapamil—Angina pectoris—Doxorubicin—testicular cancer	0.000156	0.0015	CcSEcCtD
Verapamil—ABCC3—NRF2 pathway—SLC2A6—testicular cancer	0.000155	0.025	CbGpPWpGaD
Verapamil—Nausea—Bleomycin—testicular cancer	0.000155	0.00148	CcSEcCtD
Verapamil—Drowsiness—Epirubicin—testicular cancer	0.000155	0.00148	CcSEcCtD
Verapamil—Vomiting—Dactinomycin—testicular cancer	0.000155	0.00148	CcSEcCtD
Verapamil—ABCB1—testis—testicular cancer	0.000154	0.00326	CbGeAlD
Verapamil—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000153	0.00147	CcSEcCtD
Verapamil—Rash—Dactinomycin—testicular cancer	0.000153	0.00147	CcSEcCtD
Verapamil—CACNB1—Developmental Biology—PRDM14—testicular cancer	0.000153	0.0247	CbGpPWpGaD
Verapamil—SLC6A4—NRF2 pathway—SLC2A6—testicular cancer	0.000153	0.0246	CbGpPWpGaD
Verapamil—Diarrhoea—Ifosfamide—testicular cancer	0.000153	0.00146	CcSEcCtD
Verapamil—Fatigue—Etoposide—testicular cancer	0.000152	0.00145	CcSEcCtD
Verapamil—Jaundice—Epirubicin—testicular cancer	0.000151	0.00145	CcSEcCtD
Verapamil—Pain—Etoposide—testicular cancer	0.000151	0.00144	CcSEcCtD
Verapamil—Constipation—Etoposide—testicular cancer	0.000151	0.00144	CcSEcCtD
Verapamil—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000149	0.00143	CcSEcCtD
Verapamil—Hepatitis—Methotrexate—testicular cancer	0.000148	0.00142	CcSEcCtD
Verapamil—Sweating—Epirubicin—testicular cancer	0.000148	0.00142	CcSEcCtD
Verapamil—Pollakiuria—Doxorubicin—testicular cancer	0.000148	0.00142	CcSEcCtD
Verapamil—Dizziness—Ifosfamide—testicular cancer	0.000147	0.00141	CcSEcCtD
Verapamil—Pharyngitis—Methotrexate—testicular cancer	0.000147	0.00141	CcSEcCtD
Verapamil—ABCC4—NRF2 pathway—SLC2A6—testicular cancer	0.000146	0.0235	CbGpPWpGaD
Verapamil—Sinusitis—Epirubicin—testicular cancer	0.000145	0.00139	CcSEcCtD
Verapamil—Feeling abnormal—Etoposide—testicular cancer	0.000145	0.00139	CcSEcCtD
Verapamil—Nausea—Dactinomycin—testicular cancer	0.000144	0.00138	CcSEcCtD
Verapamil—Drowsiness—Doxorubicin—testicular cancer	0.000143	0.00137	CcSEcCtD
Verapamil—Visual impairment—Methotrexate—testicular cancer	0.000143	0.00137	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000142	0.00136	CcSEcCtD
Verapamil—Vomiting—Ifosfamide—testicular cancer	0.000142	0.00136	CcSEcCtD
Verapamil—Hypersensitivity—Cisplatin—testicular cancer	0.000142	0.00136	CcSEcCtD
Verapamil—Bradycardia—Epirubicin—testicular cancer	0.000141	0.00135	CcSEcCtD
Verapamil—SLC22A4—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000141	0.0227	CbGpPWpGaD
Verapamil—Rash—Ifosfamide—testicular cancer	0.000141	0.00135	CcSEcCtD
Verapamil—Dermatitis—Ifosfamide—testicular cancer	0.00014	0.00135	CcSEcCtD
Verapamil—Erythema multiforme—Methotrexate—testicular cancer	0.00014	0.00134	CcSEcCtD
Verapamil—Urticaria—Etoposide—testicular cancer	0.00014	0.00134	CcSEcCtD
Verapamil—Jaundice—Doxorubicin—testicular cancer	0.00014	0.00134	CcSEcCtD
Verapamil—Rhinitis—Epirubicin—testicular cancer	0.000139	0.00133	CcSEcCtD
Verapamil—Hepatitis—Epirubicin—testicular cancer	0.000139	0.00133	CcSEcCtD
Verapamil—Tinnitus—Methotrexate—testicular cancer	0.000138	0.00133	CcSEcCtD
Verapamil—Hypoaesthesia—Epirubicin—testicular cancer	0.000138	0.00132	CcSEcCtD
Verapamil—Asthenia—Cisplatin—testicular cancer	0.000138	0.00132	CcSEcCtD
Verapamil—Pharyngitis—Epirubicin—testicular cancer	0.000138	0.00132	CcSEcCtD
Verapamil—Sweating—Doxorubicin—testicular cancer	0.000137	0.00132	CcSEcCtD
Verapamil—Oedema peripheral—Epirubicin—testicular cancer	0.000137	0.00131	CcSEcCtD
Verapamil—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000137	0.0221	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—PRDM14—testicular cancer	0.000137	0.022	CbGpPWpGaD
Verapamil—Sinusitis—Doxorubicin—testicular cancer	0.000134	0.00129	CcSEcCtD
Verapamil—Visual impairment—Epirubicin—testicular cancer	0.000134	0.00128	CcSEcCtD
Verapamil—Nausea—Ifosfamide—testicular cancer	0.000132	0.00127	CcSEcCtD
Verapamil—CACNA1H—Developmental Biology—PRDM14—testicular cancer	0.000132	0.0213	CbGpPWpGaD
Verapamil—Diarrhoea—Cisplatin—testicular cancer	0.000131	0.00126	CcSEcCtD
Verapamil—Erythema multiforme—Epirubicin—testicular cancer	0.000131	0.00126	CcSEcCtD
Verapamil—Alopecia—Methotrexate—testicular cancer	0.000131	0.00126	CcSEcCtD
Verapamil—Bradycardia—Doxorubicin—testicular cancer	0.000131	0.00125	CcSEcCtD
Verapamil—Hypersensitivity—Etoposide—testicular cancer	0.00013	0.00124	CcSEcCtD
Verapamil—Tinnitus—Epirubicin—testicular cancer	0.00013	0.00124	CcSEcCtD
Verapamil—Flushing—Epirubicin—testicular cancer	0.000129	0.00124	CcSEcCtD
Verapamil—Rhinitis—Doxorubicin—testicular cancer	0.000129	0.00123	CcSEcCtD
Verapamil—Hepatitis—Doxorubicin—testicular cancer	0.000129	0.00123	CcSEcCtD
Verapamil—ABCC10—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000128	0.0207	CbGpPWpGaD
Verapamil—Hypoaesthesia—Doxorubicin—testicular cancer	0.000128	0.00123	CcSEcCtD
Verapamil—Pharyngitis—Doxorubicin—testicular cancer	0.000128	0.00122	CcSEcCtD
Verapamil—Oedema peripheral—Doxorubicin—testicular cancer	0.000127	0.00121	CcSEcCtD
Verapamil—Asthenia—Etoposide—testicular cancer	0.000126	0.00121	CcSEcCtD
Verapamil—CACNA1A—Integration of energy metabolism—STK11—testicular cancer	0.000125	0.0202	CbGpPWpGaD
Verapamil—Pruritus—Etoposide—testicular cancer	0.000125	0.00119	CcSEcCtD
Verapamil—Visual impairment—Doxorubicin—testicular cancer	0.000124	0.00119	CcSEcCtD
Verapamil—ABCC2—NRF2 pathway—SLC2A6—testicular cancer	0.000123	0.0198	CbGpPWpGaD
Verapamil—Alopecia—Epirubicin—testicular cancer	0.000123	0.00118	CcSEcCtD
Verapamil—Vomiting—Cisplatin—testicular cancer	0.000122	0.00117	CcSEcCtD
Verapamil—Vision blurred—Methotrexate—testicular cancer	0.000122	0.00117	CcSEcCtD
Verapamil—Erythema multiforme—Doxorubicin—testicular cancer	0.000122	0.00116	CcSEcCtD
Verapamil—Rash—Cisplatin—testicular cancer	0.000121	0.00116	CcSEcCtD
Verapamil—Dermatitis—Cisplatin—testicular cancer	0.000121	0.00116	CcSEcCtD
Verapamil—Diarrhoea—Etoposide—testicular cancer	0.00012	0.00115	CcSEcCtD
Verapamil—Tinnitus—Doxorubicin—testicular cancer	0.00012	0.00115	CcSEcCtD
Verapamil—Flushing—Doxorubicin—testicular cancer	0.000119	0.00114	CcSEcCtD
Verapamil—CACNB3—Integration of energy metabolism—STK11—testicular cancer	0.000118	0.019	CbGpPWpGaD
Verapamil—KCNH2—Hematopoietic Stem Cell Differentiation—KITLG—testicular cancer	0.000117	0.0188	CbGpPWpGaD
Verapamil—Dizziness—Etoposide—testicular cancer	0.000116	0.00112	CcSEcCtD
Verapamil—Muscle spasms—Epirubicin—testicular cancer	0.000116	0.00111	CcSEcCtD
Verapamil—Vertigo—Methotrexate—testicular cancer	0.000116	0.00111	CcSEcCtD
Verapamil—Nausea—Cisplatin—testicular cancer	0.000114	0.00109	CcSEcCtD
Verapamil—Vision blurred—Epirubicin—testicular cancer	0.000114	0.00109	CcSEcCtD
Verapamil—Alopecia—Doxorubicin—testicular cancer	0.000114	0.00109	CcSEcCtD
Verapamil—CACNA1S—Developmental Biology—PRDM14—testicular cancer	0.000112	0.0181	CbGpPWpGaD
Verapamil—Convulsion—Methotrexate—testicular cancer	0.000112	0.00107	CcSEcCtD
Verapamil—ABCB1—lymph node—testicular cancer	0.000112	0.00236	CbGeAlD
Verapamil—Vomiting—Etoposide—testicular cancer	0.000112	0.00107	CcSEcCtD
Verapamil—Agitation—Epirubicin—testicular cancer	0.000111	0.00106	CcSEcCtD
Verapamil—Rash—Etoposide—testicular cancer	0.000111	0.00106	CcSEcCtD
Verapamil—Dermatitis—Etoposide—testicular cancer	0.000111	0.00106	CcSEcCtD
Verapamil—Headache—Etoposide—testicular cancer	0.00011	0.00106	CcSEcCtD
Verapamil—Myalgia—Methotrexate—testicular cancer	0.00011	0.00105	CcSEcCtD
Verapamil—Chest pain—Methotrexate—testicular cancer	0.00011	0.00105	CcSEcCtD
Verapamil—Arthralgia—Methotrexate—testicular cancer	0.00011	0.00105	CcSEcCtD
Verapamil—Discomfort—Methotrexate—testicular cancer	0.000109	0.00104	CcSEcCtD
Verapamil—Vertigo—Epirubicin—testicular cancer	0.000109	0.00104	CcSEcCtD
Verapamil—Syncope—Epirubicin—testicular cancer	0.000108	0.00104	CcSEcCtD
Verapamil—Muscle spasms—Doxorubicin—testicular cancer	0.000108	0.00103	CcSEcCtD
Verapamil—Palpitations—Epirubicin—testicular cancer	0.000107	0.00102	CcSEcCtD
Verapamil—Confusional state—Methotrexate—testicular cancer	0.000106	0.00102	CcSEcCtD
Verapamil—Loss of consciousness—Epirubicin—testicular cancer	0.000106	0.00102	CcSEcCtD
Verapamil—SLC22A5—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000106	0.0171	CbGpPWpGaD
Verapamil—Anaphylactic shock—Methotrexate—testicular cancer	0.000105	0.00101	CcSEcCtD
Verapamil—Vision blurred—Doxorubicin—testicular cancer	0.000105	0.00101	CcSEcCtD
Verapamil—Convulsion—Epirubicin—testicular cancer	0.000105	0.001	CcSEcCtD
Verapamil—Infection—Methotrexate—testicular cancer	0.000105	0.001	CcSEcCtD
Verapamil—Nausea—Etoposide—testicular cancer	0.000105	0.001	CcSEcCtD
Verapamil—Hypertension—Epirubicin—testicular cancer	0.000104	0.001	CcSEcCtD
Verapamil—ABCC1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000104	0.0168	CbGpPWpGaD
Verapamil—Arthralgia—Epirubicin—testicular cancer	0.000103	0.000986	CcSEcCtD
Verapamil—Myalgia—Epirubicin—testicular cancer	0.000103	0.000986	CcSEcCtD
Verapamil—Chest pain—Epirubicin—testicular cancer	0.000103	0.000986	CcSEcCtD
Verapamil—Agitation—Doxorubicin—testicular cancer	0.000103	0.000985	CcSEcCtD
Verapamil—Hyperhidrosis—Methotrexate—testicular cancer	0.000102	0.000977	CcSEcCtD
Verapamil—Discomfort—Epirubicin—testicular cancer	0.000102	0.000974	CcSEcCtD
Verapamil—Dry mouth—Epirubicin—testicular cancer	0.000101	0.000965	CcSEcCtD
Verapamil—Vertigo—Doxorubicin—testicular cancer	0.000101	0.000963	CcSEcCtD
Verapamil—Syncope—Doxorubicin—testicular cancer	0.0001	0.000961	CcSEcCtD
Verapamil—Confusional state—Epirubicin—testicular cancer	9.95e-05	0.000953	CcSEcCtD
Verapamil—Palpitations—Doxorubicin—testicular cancer	9.89e-05	0.000947	CcSEcCtD
Verapamil—Oedema—Epirubicin—testicular cancer	9.87e-05	0.000946	CcSEcCtD
Verapamil—Anaphylactic shock—Epirubicin—testicular cancer	9.87e-05	0.000946	CcSEcCtD
Verapamil—Hypotension—Methotrexate—testicular cancer	9.85e-05	0.000944	CcSEcCtD
Verapamil—Loss of consciousness—Doxorubicin—testicular cancer	9.83e-05	0.000942	CcSEcCtD
Verapamil—Infection—Epirubicin—testicular cancer	9.8e-05	0.000939	CcSEcCtD
Verapamil—Shock—Epirubicin—testicular cancer	9.71e-05	0.00093	CcSEcCtD
Verapamil—Convulsion—Doxorubicin—testicular cancer	9.69e-05	0.000929	CcSEcCtD
Verapamil—Hypertension—Doxorubicin—testicular cancer	9.66e-05	0.000925	CcSEcCtD
Verapamil—Tachycardia—Epirubicin—testicular cancer	9.63e-05	0.000923	CcSEcCtD
Verapamil—CACNB2—Developmental Biology—PRDM14—testicular cancer	9.62e-05	0.0155	CbGpPWpGaD
Verapamil—Musculoskeletal discomfort—Methotrexate—testicular cancer	9.61e-05	0.00092	CcSEcCtD
Verapamil—Hyperhidrosis—Epirubicin—testicular cancer	9.54e-05	0.000914	CcSEcCtD
Verapamil—Insomnia—Methotrexate—testicular cancer	9.54e-05	0.000914	CcSEcCtD
Verapamil—Arthralgia—Doxorubicin—testicular cancer	9.53e-05	0.000913	CcSEcCtD
Verapamil—Chest pain—Doxorubicin—testicular cancer	9.53e-05	0.000913	CcSEcCtD
Verapamil—Myalgia—Doxorubicin—testicular cancer	9.53e-05	0.000913	CcSEcCtD
Verapamil—Paraesthesia—Methotrexate—testicular cancer	9.47e-05	0.000907	CcSEcCtD
Verapamil—Discomfort—Doxorubicin—testicular cancer	9.41e-05	0.000902	CcSEcCtD
Verapamil—Dyspnoea—Methotrexate—testicular cancer	9.4e-05	0.000901	CcSEcCtD
Verapamil—Somnolence—Methotrexate—testicular cancer	9.37e-05	0.000898	CcSEcCtD
Verapamil—Dry mouth—Doxorubicin—testicular cancer	9.32e-05	0.000893	CcSEcCtD
Verapamil—Dyspepsia—Methotrexate—testicular cancer	9.28e-05	0.000889	CcSEcCtD
Verapamil—Hypotension—Epirubicin—testicular cancer	9.22e-05	0.000884	CcSEcCtD
Verapamil—Confusional state—Doxorubicin—testicular cancer	9.21e-05	0.000882	CcSEcCtD
Verapamil—Anaphylactic shock—Doxorubicin—testicular cancer	9.13e-05	0.000875	CcSEcCtD
Verapamil—Oedema—Doxorubicin—testicular cancer	9.13e-05	0.000875	CcSEcCtD
Verapamil—CACNA1D—Developmental Biology—PRDM14—testicular cancer	9.11e-05	0.0147	CbGpPWpGaD
Verapamil—Fatigue—Methotrexate—testicular cancer	9.09e-05	0.000871	CcSEcCtD
Verapamil—Infection—Doxorubicin—testicular cancer	9.07e-05	0.000869	CcSEcCtD
Verapamil—Pain—Methotrexate—testicular cancer	9.02e-05	0.000864	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Epirubicin—testicular cancer	8.99e-05	0.000861	CcSEcCtD
Verapamil—Shock—Doxorubicin—testicular cancer	8.98e-05	0.000861	CcSEcCtD
Verapamil—Insomnia—Epirubicin—testicular cancer	8.93e-05	0.000855	CcSEcCtD
Verapamil—Tachycardia—Doxorubicin—testicular cancer	8.91e-05	0.000854	CcSEcCtD
Verapamil—Paraesthesia—Epirubicin—testicular cancer	8.86e-05	0.000849	CcSEcCtD
Verapamil—Hyperhidrosis—Doxorubicin—testicular cancer	8.83e-05	0.000846	CcSEcCtD
Verapamil—Dyspnoea—Epirubicin—testicular cancer	8.8e-05	0.000843	CcSEcCtD
Verapamil—Somnolence—Epirubicin—testicular cancer	8.77e-05	0.000841	CcSEcCtD
Verapamil—Feeling abnormal—Methotrexate—testicular cancer	8.69e-05	0.000833	CcSEcCtD
Verapamil—Dyspepsia—Epirubicin—testicular cancer	8.69e-05	0.000832	CcSEcCtD
Verapamil—Hypotension—Doxorubicin—testicular cancer	8.53e-05	0.000817	CcSEcCtD
Verapamil—SLCO1A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	8.51e-05	0.0137	CbGpPWpGaD
Verapamil—Fatigue—Epirubicin—testicular cancer	8.51e-05	0.000815	CcSEcCtD
Verapamil—Pain—Epirubicin—testicular cancer	8.44e-05	0.000809	CcSEcCtD
Verapamil—Constipation—Epirubicin—testicular cancer	8.44e-05	0.000809	CcSEcCtD
Verapamil—Urticaria—Methotrexate—testicular cancer	8.38e-05	0.000803	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Doxorubicin—testicular cancer	8.32e-05	0.000797	CcSEcCtD
Verapamil—Insomnia—Doxorubicin—testicular cancer	8.26e-05	0.000791	CcSEcCtD
Verapamil—Paraesthesia—Doxorubicin—testicular cancer	8.2e-05	0.000786	CcSEcCtD
Verapamil—Dyspnoea—Doxorubicin—testicular cancer	8.14e-05	0.00078	CcSEcCtD
Verapamil—Feeling abnormal—Epirubicin—testicular cancer	8.13e-05	0.000779	CcSEcCtD
Verapamil—Somnolence—Doxorubicin—testicular cancer	8.12e-05	0.000778	CcSEcCtD
Verapamil—SCN5A—Developmental Biology—PRDM14—testicular cancer	8.09e-05	0.013	CbGpPWpGaD
Verapamil—Dyspepsia—Doxorubicin—testicular cancer	8.04e-05	0.00077	CcSEcCtD
Verapamil—CACNA1C—Developmental Biology—PRDM14—testicular cancer	8.01e-05	0.0129	CbGpPWpGaD
Verapamil—Fatigue—Doxorubicin—testicular cancer	7.87e-05	0.000754	CcSEcCtD
Verapamil—Urticaria—Epirubicin—testicular cancer	7.84e-05	0.000751	CcSEcCtD
Verapamil—Pain—Doxorubicin—testicular cancer	7.81e-05	0.000748	CcSEcCtD
Verapamil—Constipation—Doxorubicin—testicular cancer	7.81e-05	0.000748	CcSEcCtD
Verapamil—Hypersensitivity—Methotrexate—testicular cancer	7.77e-05	0.000744	CcSEcCtD
Verapamil—Asthenia—Methotrexate—testicular cancer	7.57e-05	0.000725	CcSEcCtD
Verapamil—Feeling abnormal—Doxorubicin—testicular cancer	7.52e-05	0.000721	CcSEcCtD
Verapamil—Pruritus—Methotrexate—testicular cancer	7.46e-05	0.000715	CcSEcCtD
Verapamil—SLCO1B1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	7.28e-05	0.0117	CbGpPWpGaD
Verapamil—Hypersensitivity—Epirubicin—testicular cancer	7.27e-05	0.000697	CcSEcCtD
Verapamil—Urticaria—Doxorubicin—testicular cancer	7.25e-05	0.000695	CcSEcCtD
Verapamil—Diarrhoea—Methotrexate—testicular cancer	7.22e-05	0.000691	CcSEcCtD
Verapamil—CACNB2—Integration of energy metabolism—STK11—testicular cancer	7.19e-05	0.0116	CbGpPWpGaD
Verapamil—SLC22A4—Transmembrane transport of small molecules—SLC2A6—testicular cancer	7.16e-05	0.0116	CbGpPWpGaD
Verapamil—Asthenia—Epirubicin—testicular cancer	7.08e-05	0.000678	CcSEcCtD
Verapamil—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—testicular cancer	7.05e-05	0.0114	CbGpPWpGaD
Verapamil—Pruritus—Epirubicin—testicular cancer	6.98e-05	0.000669	CcSEcCtD
Verapamil—Dizziness—Methotrexate—testicular cancer	6.97e-05	0.000668	CcSEcCtD
Verapamil—KCNJ11—Integration of energy metabolism—STK11—testicular cancer	6.86e-05	0.0111	CbGpPWpGaD
Verapamil—CACNA1D—Integration of energy metabolism—STK11—testicular cancer	6.81e-05	0.011	CbGpPWpGaD
Verapamil—Diarrhoea—Epirubicin—testicular cancer	6.75e-05	0.000647	CcSEcCtD
Verapamil—Hypersensitivity—Doxorubicin—testicular cancer	6.73e-05	0.000645	CcSEcCtD
Verapamil—Vomiting—Methotrexate—testicular cancer	6.7e-05	0.000642	CcSEcCtD
Verapamil—Rash—Methotrexate—testicular cancer	6.65e-05	0.000637	CcSEcCtD
Verapamil—Dermatitis—Methotrexate—testicular cancer	6.64e-05	0.000636	CcSEcCtD
Verapamil—Headache—Methotrexate—testicular cancer	6.61e-05	0.000633	CcSEcCtD
Verapamil—Asthenia—Doxorubicin—testicular cancer	6.55e-05	0.000628	CcSEcCtD
Verapamil—SCN5A—Cardiac Progenitor Differentiation—KIT—testicular cancer	6.55e-05	0.0106	CbGpPWpGaD
Verapamil—Dizziness—Epirubicin—testicular cancer	6.53e-05	0.000625	CcSEcCtD
Verapamil—Pruritus—Doxorubicin—testicular cancer	6.46e-05	0.000619	CcSEcCtD
Verapamil—Vomiting—Epirubicin—testicular cancer	6.27e-05	0.000601	CcSEcCtD
Verapamil—Nausea—Methotrexate—testicular cancer	6.26e-05	0.0006	CcSEcCtD
Verapamil—Diarrhoea—Doxorubicin—testicular cancer	6.25e-05	0.000599	CcSEcCtD
Verapamil—Rash—Epirubicin—testicular cancer	6.22e-05	0.000596	CcSEcCtD
Verapamil—Dermatitis—Epirubicin—testicular cancer	6.22e-05	0.000596	CcSEcCtD
Verapamil—SLC22A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	6.22e-05	0.01	CbGpPWpGaD
Verapamil—Headache—Epirubicin—testicular cancer	6.18e-05	0.000592	CcSEcCtD
Verapamil—Dizziness—Doxorubicin—testicular cancer	6.04e-05	0.000579	CcSEcCtD
Verapamil—CACNA1C—Integration of energy metabolism—STK11—testicular cancer	5.99e-05	0.00965	CbGpPWpGaD
Verapamil—Nausea—Epirubicin—testicular cancer	5.86e-05	0.000562	CcSEcCtD
Verapamil—Vomiting—Doxorubicin—testicular cancer	5.81e-05	0.000556	CcSEcCtD
Verapamil—Rash—Doxorubicin—testicular cancer	5.76e-05	0.000552	CcSEcCtD
Verapamil—Dermatitis—Doxorubicin—testicular cancer	5.75e-05	0.000551	CcSEcCtD
Verapamil—Headache—Doxorubicin—testicular cancer	5.72e-05	0.000548	CcSEcCtD
Verapamil—CYP2C8—Arachidonic acid metabolism—HPGDS—testicular cancer	5.68e-05	0.00915	CbGpPWpGaD
Verapamil—Nausea—Doxorubicin—testicular cancer	5.42e-05	0.00052	CcSEcCtD
Verapamil—SLC22A5—Transmembrane transport of small molecules—SLC2A6—testicular cancer	5.38e-05	0.00868	CbGpPWpGaD
Verapamil—CYP2C18—Biological oxidations—HPGDS—testicular cancer	5.07e-05	0.00818	CbGpPWpGaD
Verapamil—CYP2C19—Arachidonic acid metabolism—HPGDS—testicular cancer	5.07e-05	0.00817	CbGpPWpGaD
Verapamil—ABCC3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	4.97e-05	0.00801	CbGpPWpGaD
Verapamil—ABCC4—Transmembrane transport of small molecules—SLC2A6—testicular cancer	4.67e-05	0.00753	CbGpPWpGaD
Verapamil—CYP2C9—Arachidonic acid metabolism—HPGDS—testicular cancer	4.62e-05	0.00745	CbGpPWpGaD
Verapamil—SLCO1A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	4.32e-05	0.00697	CbGpPWpGaD
Verapamil—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	4.26e-05	0.00688	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	4.22e-05	0.0068	CbGpPWpGaD
Verapamil—CYP1A2—Arachidonic acid metabolism—HPGDS—testicular cancer	3.95e-05	0.00636	CbGpPWpGaD
Verapamil—ABCC2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	3.94e-05	0.00635	CbGpPWpGaD
Verapamil—ABCC1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	3.89e-05	0.00627	CbGpPWpGaD
Verapamil—SLCO1B1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	3.7e-05	0.00596	CbGpPWpGaD
Verapamil—ABCG2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	3.42e-05	0.00552	CbGpPWpGaD
Verapamil—CYP3A7—Biological oxidations—HPGDS—testicular cancer	3.37e-05	0.00544	CbGpPWpGaD
Verapamil—CACNB4—Axon guidance—MMP2—testicular cancer	3.32e-05	0.00535	CbGpPWpGaD
Verapamil—SLC22A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	3.16e-05	0.00509	CbGpPWpGaD
Verapamil—CACNA1I—Axon guidance—MMP2—testicular cancer	3.12e-05	0.00503	CbGpPWpGaD
Verapamil—CACNB3—Axon guidance—MMP2—testicular cancer	2.65e-05	0.00428	CbGpPWpGaD
Verapamil—CACNB1—Axon guidance—MMP2—testicular cancer	2.58e-05	0.00416	CbGpPWpGaD
Verapamil—CYP1A2—Phase II conjugation—HPGDS—testicular cancer	2.51e-05	0.00405	CbGpPWpGaD
Verapamil—CYP2B6—Biological oxidations—HPGDS—testicular cancer	2.49e-05	0.00402	CbGpPWpGaD
Verapamil—CYP3A5—Biological oxidations—HPGDS—testicular cancer	2.44e-05	0.00393	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—MMP2—testicular cancer	2.37e-05	0.00382	CbGpPWpGaD
Verapamil—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	2.31e-05	0.00372	CbGpPWpGaD
Verapamil—CACNA1G—Axon guidance—MMP2—testicular cancer	2.3e-05	0.00371	CbGpPWpGaD
Verapamil—CACNA1H—Axon guidance—MMP2—testicular cancer	2.23e-05	0.00359	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—MMP2—testicular cancer	2.23e-05	0.00359	CbGpPWpGaD
Verapamil—CYP2C8—Biological oxidations—HPGDS—testicular cancer	2.11e-05	0.00341	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.98e-05	0.00319	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—HPGDS—testicular cancer	1.97e-05	0.00318	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.9e-05	0.00306	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—MMP2—testicular cancer	1.89e-05	0.00305	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—MMP2—testicular cancer	1.89e-05	0.00305	CbGpPWpGaD
Verapamil—CYP2C19—Biological oxidations—HPGDS—testicular cancer	1.89e-05	0.00304	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—HPGDS—testicular cancer	1.85e-05	0.00299	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	1.85e-05	0.00299	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—MMP2—testicular cancer	1.84e-05	0.00297	CbGpPWpGaD
Verapamil—CYP2D6—Biological oxidations—HPGDS—testicular cancer	1.73e-05	0.0028	CbGpPWpGaD
Verapamil—CYP2C9—Biological oxidations—HPGDS—testicular cancer	1.72e-05	0.00277	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	1.69e-05	0.00273	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.65e-05	0.00266	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—MMP2—testicular cancer	1.64e-05	0.00265	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—MMP2—testicular cancer	1.62e-05	0.00261	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—MMP2—testicular cancer	1.59e-05	0.00257	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—MMP2—testicular cancer	1.54e-05	0.00248	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.49e-05	0.0024	CbGpPWpGaD
Verapamil—CYP1A2—Biological oxidations—HPGDS—testicular cancer	1.47e-05	0.00237	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—STK11—testicular cancer	1.43e-05	0.00231	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.41e-05	0.00228	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—MMP2—testicular cancer	1.36e-05	0.0022	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—MMP2—testicular cancer	1.35e-05	0.00218	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—MMP2—testicular cancer	1.35e-05	0.00218	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—STK11—testicular cancer	1.35e-05	0.00217	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	1.23e-05	0.00198	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—MMP2—testicular cancer	1.16e-05	0.00187	CbGpPWpGaD
Verapamil—CYP3A4—Biological oxidations—HPGDS—testicular cancer	1.13e-05	0.00183	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—HPGDS—testicular cancer	1.13e-05	0.00183	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—MMP2—testicular cancer	1.1e-05	0.00177	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—HPGDS—testicular cancer	1.08e-05	0.00174	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—HPGDS—testicular cancer	1.07e-05	0.00173	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—MMP2—testicular cancer	9.73e-06	0.00157	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—MMP2—testicular cancer	9.63e-06	0.00155	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—HPGDS—testicular cancer	9.42e-06	0.00152	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—HPGDS—testicular cancer	8.81e-06	0.00142	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—HPGDS—testicular cancer	8.68e-06	0.0014	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—HPGDS—testicular cancer	8.44e-06	0.00136	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—STK11—testicular cancer	8.23e-06	0.00133	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	8.11e-06	0.00131	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—STK11—testicular cancer	7.85e-06	0.00127	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—STK11—testicular cancer	7.79e-06	0.00126	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—HPGDS—testicular cancer	7.35e-06	0.00119	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	7.24e-06	0.00117	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—STK11—testicular cancer	6.85e-06	0.0011	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—HPGDS—testicular cancer	6.61e-06	0.00107	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	6.6e-06	0.00106	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—STK11—testicular cancer	6.4e-06	0.00103	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—STK11—testicular cancer	6.31e-06	0.00102	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—HPGDS—testicular cancer	6.29e-06	0.00101	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—STK11—testicular cancer	6.13e-06	0.000989	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—HPGDS—testicular cancer	5.82e-06	0.000939	CbGpPWpGaD
Verapamil—ABCC1—Disease—H2AFZ—testicular cancer	5.77e-06	0.000931	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—HPGDS—testicular cancer	5.77e-06	0.00093	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	5.64e-06	0.00091	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—HPGDS—testicular cancer	5.37e-06	0.000866	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—STK11—testicular cancer	5.34e-06	0.000861	CbGpPWpGaD
Verapamil—ABCC1—Disease—KITLG—testicular cancer	5.31e-06	0.000856	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—STK11—testicular cancer	4.81e-06	0.000775	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—STK11—testicular cancer	4.57e-06	0.000737	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—HPGDS—testicular cancer	4.27e-06	0.000688	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—STK11—testicular cancer	4.23e-06	0.000682	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—STK11—testicular cancer	4.19e-06	0.000676	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—HPGDS—testicular cancer	4.17e-06	0.000672	CbGpPWpGaD
Verapamil—ABCC1—Disease—FGFR3—testicular cancer	3.95e-06	0.000636	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—STK11—testicular cancer	3.9e-06	0.000629	CbGpPWpGaD
Verapamil—ABCC1—Disease—KIT—testicular cancer	3.62e-06	0.000584	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—HPGDS—testicular cancer	3.61e-06	0.000582	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—HPGDS—testicular cancer	3.22e-06	0.00052	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—HPGDS—testicular cancer	3.15e-06	0.000507	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—STK11—testicular cancer	3.1e-06	0.0005	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—STK11—testicular cancer	3.03e-06	0.000489	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—HPGDS—testicular cancer	2.97e-06	0.000478	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—HPGDS—testicular cancer	2.94e-06	0.000474	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—STK11—testicular cancer	2.62e-06	0.000423	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—HPGDS—testicular cancer	2.51e-06	0.000405	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—STK11—testicular cancer	2.34e-06	0.000378	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—STK11—testicular cancer	2.29e-06	0.000369	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—STK11—testicular cancer	2.15e-06	0.000347	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—STK11—testicular cancer	2.14e-06	0.000344	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—HPGDS—testicular cancer	1.94e-06	0.000313	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—STK11—testicular cancer	1.83e-06	0.000294	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—STK11—testicular cancer	1.41e-06	0.000227	CbGpPWpGaD
